BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2020
View Archived Issues
Faulty exon splicing is cause of rare subtype of Parkinson's disease, pointing to new drug targets
Read More
Positive preclinical data for novel COVID-19 vaccine, ACvac1
Read More
Key initial results reported from phase I study of CPI-006 for patients with COVID-19
Read More
FDA clears IND for phase I study of APR-003
Read More
Room for improvement in T-cell repertoire profiling
Read More
Results from phase II CENTAUR study of sodium phenylbutyrate/taurursodiol in ALS
Read More
Voronoi patents new RET inhibitors
Read More
Galapagos discloses PASK inhibitors
Read More
Aerie Pharmaceuticals presents new Rho and JAK inhibitors
Read More
Discovery of novel orally active and selective PI3Kalpha inhibitor
Read More
Constellation Pharmaceuticals discovers new CBP and KAT3B inhibitors
Read More
New phase II trial examines suprachoroidal administration of AU-011 in primary choroidal melanoma
Read More
Proof-of-concept study of ziritaxestat in diffuse cutaneous systemic sclerosis meets endpoint
Read More
New antibacterials presented by Viridias
Read More
Topadur begins phase I study of TOP-N53 for wound healing
Read More
QBW-251: a CFTR potentiator in phase II for the treatment of COPD
Read More
Phase III trial of Fasenra in nasal polyposis meets coprimary endpoints
Read More
Bicycle opens phase I/II study of BT-8009 in advanced solid tumors
Read More
FCN-437c enters phase II trial in China for advanced breast cancer
Read More
Pentamidine targets S100B to improve experimental multiple sclerosis
Read More
SanBio reports new phase IIb analyses for SB-623 in chronic motor deficit from ischemic stroke
Read More
Gemini begins phase IIa study of GEM-103 for dry AMD
Read More
Novartis describes discovery and clinical results with ERK1/2 inhibitor LTT-462
Read More
Sutro reports updated phase I data on STRO-002 in advanced ovarian cancer
Read More
KITE study of Beovu in DME meets primary and key secondary endpoints
Read More
Dimerix reports phase II data on DMX-200 in diabetic kidney disease
Read More
Enanta begins phase I study of EDP-297 for NASH
Read More
FDA approves Trelegy Ellipta for asthma
Read More